Gates-backed startup promises ‘rapid’ development of problematic mRNA vaccines
The Bill and Melinda Gates Foundation is investing in a biopharmaceutical company's therapies despite repeated warnings of potential dangers.
•
You have not enabled cookies! This site requires cookies to operate properly. Please enable cookies, and refresh your browser for full functionality.